Method and system for parameterizing a high intensity focused ultrasound therapy device - Patents.com
The meta-model based parameterization system for HIFU treatment devices rapidly simulates and optimizes tissue ablation by using patient-specific parameters, addressing computational inefficiencies in existing methods and enabling efficient outpatient treatments.
Patent Information
- Application Number
- JP2024535648
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-17
- Filing Date
- 2022-12-16
- Publication Date
- 2024-12-03
AI Technical Summary
Existing HIFU treatment simulations for tissue ablation are computationally intensive and time-consuming, especially when modeling heterogeneous tissue environments, making them unsuitable for outpatient treatments.
A parameterization method and system using a meta-model to estimate ultrasound fields based on patient-specific geometric and physiological parameters, allowing for rapid simulation and adjustment of treatment parameters to optimize tissue necrosis and sparing using a database of pre-computed ultrasound field maps.
Enables near-real-time simulation and optimization of HIFU treatment protocols, ensuring accurate tissue ablation while sparing healthy tissue, thus facilitating outpatient treatments.
Smart Images

Figure 2024544714000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates generally to a therapeutic device using high intensity focused ultrasound (HIFU), and in particular to the use of the device to destroy tumors by remote thermal ablation while sparing intermediate tissue. [Background technology]
[0002] High-intensity focused ultrasound (HIFU) therapy involves the use of the energy of a focused ultrasound beam to modify or destroy biological tissue. Tissue is destroyed by protein coagulation, which causes irreversible cellular damage and apoptosis.
[0003] This technique is widely used for thermal ablation of benign or malignant tumors (prostate cancer, liver metastases, or brain tumors). The technique has the advantage of being percutaneous (i.e., non-invasive) and sparing the surrounding healthy tissue.
[0004] HIFU treatment generally uses a phased array multi-transducer probe. For each ultrasound shot, delay and amplitude laws are applied to the various elements of the transducer to form a focused beam at a given point. This operation is repeated at different points within the target area to be destroyed, selecting the repetition rate (repetition frequency) and pulse energy.
[0005] Before applying a treatment protocol, the practitioner must ensure that the amount of heat applied is sufficient to destroy the target area while sparing healthy areas. To do this, the target area is meshed with a grid of points, and a simulation of focused ultrasound shots is performed at each point on the grid, or at groups of adjacent points. The temperature rise at each point is then estimated by solving the heat transfer equation in the tissue. One method for validating HIFU treatment protocols is described in US Pat. No. 6,399,433.
[0006] This simulation method works relatively well when the medium through which the ultrasound propagates is homogeneous, but becomes quite complicated when several tissue sites must be modeled, especially when high spatial resolution is required. Thus, simulating an ultrasound field based on the characteristics of various tissues of a patient can take several hours on a conventional personal computer, which is not suitable for outpatient treatment.
[0007] It is also proposed to significantly speed up the simulation of HIFU treatment by using a metamodel generated from a simulated database. This can be achieved by defining a set of N uncertain parameters, in this case the patient's physiological and anatomical parameters that affect the simulation, as well as their assumed range of variation. This database can be obtained by performing a one-time (offline) simulation of the ultrasound field for all possible configurations in this space of dimension N (basic configurations). This first simulation gives the ultrasound pressure field distribution for each basic configuration.
[0008] A second simulation is then performed (online) by interpolating the simulation results obtained for various previous configurations, i.e. by interpolating the ultrasonic pressure field contained in the database. This is called metamodeling, since it involves replacing the direct simulation model, which is assumed to be accurate, with a much faster, even real-time, interpolator that is able to control the errors.
[0009] A method for simulating such a HIFU ultrasound field is described in the paper "Applications of intensive HIFU simulation based on surrogate models using the CIVA HealthCare Platform" by S. Chatillon et al., published in the Journal of the Physical Society of Japan, Vol. 1761, 2021.
[0010] With complete knowledge of the patient's physiological and anatomical parameters, the simulation method allows to estimate the lesions that will result from the established protocol, thus making it possible to check whether it complies with the restrictions imposed on the target areas to be destroyed and the healthy tissue to be preserved. If the treatment protocol that the practitioner comes up with does not comply with the above restrictions, the practitioner must empirically modify it and perform a new online simulation. The convergence of the process is relatively slow and may result in a suboptimal solution.
[0011] Therefore, the object of the present invention is to propose a parameterization method and system embedded in a HIFU treatment device that does not have the above-mentioned drawbacks and can very quickly perform sub-optimal parameterization based in particular on the patient's physiological parameters, the target areas to be necrosed, and the healthy areas to be preserved. [Prior art documents] [Patent documents]
[0012] [Patent Document 1] US Patent Application Publication No. 2021 / 0000541 Summary of the Invention
[0013] The present invention is defined by a method for parameterizing a HIFU treatment device comprising an ultrasound probe for necrosing at least one tissue region of a treated area of a patient, said treatment comprising a plurality of ultrasound shots, and said treatment parameters defining, inter alia, the position and orientation of the probe for each shot relative to the treated area, said treated area being modeled by different tissue regions comprising at least one necrosed tissue region and one preserved tissue region, each tissue region being characterized by geometrical and physiological parameters, said parameterization method comprising: - estimating the ultrasound field in the treated area by means of a meta-model using a database in which pre-computed ultrasound field maps for different values of geometric and physiological parameters of each tissue region of the area are stored, the ultrasound field estimate being obtained by interpolation of the pre-computed maps; estimating, from the ultrasound field within the region, the amount of heat to be applied to each point on the grid within the treatment region; estimating tissue response at each point on said grid to determine whether the applied thermal dose will cause necrosis at that point, thereby defining an estimated region of necrosis and an estimated region of sparing; and adjusting treatment parameters to minimize a cost function that depends on the difference between the estimated necrotic area and the area of necrotic tissue, provided that the area to be spared is within the estimated area to be spared.
[0014] The treatment parameters may also include the duration and repetition rate of the ultrasound shots.
[0015] If the probe includes multiple transducers, the treatment parameters may include a phase and / or frequency and / or power law to be applied to all of the transducer elements.
[0016] The physiological parameters of the tissue region include, for example, at least one of the following parameters: density, specific heat, tissue thermal conductivity, blood or tissue blood perfusion rate.
[0017] The ultrasound field can be estimated in the probe's local reference frame by interpolating the pre-computed maps, and the distribution of the ultrasound field within the treatment area is inferred by changing the reference frame.
[0018] Advantageously, the thermal dose is estimated by solving the heat transfer equation in different tissue regions, taking into account the ultrasonic energy absorbed at each point on the grid during each ultrasonic shot.
[0019] The outcome of the treatment can be simulated by calculating the amount of heat absorbed at each point on the grid in the form of an exposure time equivalent to a reference temperature, and tissue is considered to be necrotic at that point if the time exceeds a given threshold, and is considered to be spared otherwise.
[0020] According to an alternative embodiment, the cost function depends on the difference between the extent of the necrotic tissue area and the extent of the estimated necrotic tissue area.
[0021] The cost function can be defined in a variety of ways.
[0022] According to an alternative embodiment, the cost function is defined as the sum of unit cost functions associated with each of the shots. According to an alternative embodiment, the cost function comprises a sum of a number of unitary cost functions, each of which is associated with one shot with the necrotic tissue area or with a sub-area of the necrotic tissue area, and / or the difference between the area or subarea estimated to be necrotic due to one or more shots and the corresponding necrotic area or subarea; The volume of healthy tissue necrotized after one or more shots, The overall duration of one or more shots, The number of probe positions to perform a set of shots, especially all of the shots; the pause between two successive shots or the sum of such pauses, is a function intended to minimize or maximize at least one objective selected from among
[0023] To summarise this, the one or more unit cost functions may be one or more functions resulting from all of the shots provided by the treatment and therefore specifically aimed at covering all of the one or more necrotic tissue regions.
[0024] A subregion of the necrotic tissue region is a part of this region.
[0025] If a unit cost function is associated with each different shot, preferably these different shots are directed to different sub-regions of the necrotic tissue area.
[0026] If a unitary cost function is associated with a sub-region of the necrotic area, then one (single) shot or multiple shots may be provided to that sub-region.
[0027] In a particular alternative embodiment, each of the unit cost functions is associated with a respective one of the different shots, the different shots preferably being directed to distinct sub-regions of the necrotic region.
[0028] In certain alternative embodiments, one shot or multiple shots are provided for each subregion of the necrotic region, with each unit cost function being associated with a respective subregion of the necrotic region.
[0029] Furthermore, in certain alternative embodiments, the cost function is defined by a sum of unitary cost functions, each of which aims to minimize at least one objective to be minimized, selected from among the above-mentioned objectives.
[0030] According to certain alternative embodiments, the treatment parameters are iteratively adjusted using gradient descent, stochastic gradient descent, or a genetic algorithm.
[0031] For at least one treatment parameter adjustment iteration, the estimated necrotic tissue area and / or the estimated spared tissue area are advantageously displayed on a display such that the necrotic tissue area and / or the spared tissue area are overlaid on an image of the treated area.
[0032] The invention further relates to a system for parameterizing a HIFU treatment device comprising an ultrasound probe for necrosing at least one tissue region of a treated area of a patient, said treatment comprising a plurality of ultrasound shots and characterized by treatment parameters defining in particular the position and orientation of the probe for each shot with respect to the treated area, said treated area being modeled by different regions comprising at least one necrosed tissue region and one preserved tissue region, each tissue region being characterized by geometrical and physiological parameters, said parameterization system comprising: a module for estimating an ultrasound field in a treatment site by means of a meta-model using a database in which pre-computed ultrasound field maps for different values of geometric and physiological parameters of each tissue region of said site are stored, said module estimating the ultrasound field by interpolation of the pre-computed maps extracted from said database; a module for estimating, from the ultrasound field in the region, the amount of heat to be applied to each point on the grid in the treatment region; a module for estimating tissue response at each point on said grid to determine whether the applied thermal dose will cause necrosis at that point, thereby defining an estimated region of necrosis and an estimated region of sparing; and a module for adjusting treatment parameters, provided that the region to be preserved is within the estimated region to be preserved, to minimize a cost function that depends on the difference between the estimated region of necrosis and the region of necrotic tissue to be preserved.
[0033] The treatment parameters further include the duration and repetition rate of the ultrasound shots.
[0034] If the probe includes multiple transducers, the treatment parameters may include a phase and / or frequency and / or power law to be applied to all of the transducer elements. [Brief description of the drawings]
[0035] Other characteristics and advantages of the present invention will become apparent from a reading of the following description of preferred embodiments thereof, which is to be read in conjunction with the accompanying drawings, in which: [Figure 1] 1 illustrates diagrammatically a system for parameterizing a HIFU Treatment Device, in accordance with one embodiment of the present invention; [Diagram 2] FIG. 2 shows diagrammatically a simulation module used in the parameterization system shown in FIG. 1; [Diagram 3] FIG. 2 shows diagrammatically the method for predicting the distribution of ultrasonic field intensity used. [Figure 4] FIG. 3 shows diagrammatically the method for estimating the amount of heat applied to the treatment site used in FIG. 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0036] In the following, a high intensity focused ultrasound therapy device as described in the introduction is described. This device can be equipped with a single piezoelectric transducer probe, whose geometry determines the focusing law, or more generally, a multi-transducer probe, whose focusing law is determined by the distribution of acoustic power and delay on the various piezoelectric elements. In the following description, for the sake of illustration and without loss of generality, it is assumed that the probe is a multi-transducer probe. The treatment is performed by successive shots, each shot corresponding to the application of a given distribution of phase, amplitude or frequency. When an inhomogeneous medium is present between the transducer and the target site, a specific phase, amplitude or frequency value is applied to each transducer element. For example, absorption by a medium with high acoustic attenuation (e.g. an organ or a tumor) can be compensated by increasing the power of a particular transducer element or by decreasing the transmission frequency to balance the energy contribution at the focal point.
[0037] The present invention is based on providing a plug-in module that can be added to or integrated into the HIFU Treatment Apparatus in order to parameterize the ultrasound probe for a given treatment site.
[0038] More specifically, the practitioner first defines the area to be treated on the patient's body, which includes areas to be necrotized (cancerous tissue, metastases, etc.) by the thermal effect (raising the local temperature to a predetermined threshold for a given period of time) and areas to be preserved (healthy tissue).
[0039] FIG. 1 shows diagrammatically a HIFU treatment device associated with a parameterization system according to the present invention.
[0040] The HIFU device is designated by reference numeral 150 and has an ultrasound probe 160 attached thereto.
[0041] The parameterization system 100 can receive data from the HIFU device that is indicative of characteristics of the area to be treated and the probe, and in return can provide parameters for applying radio frequency insonification to the area.
[0042] The parameterization system essentially comprises a simulation module 140 which is used to estimate, shot by shot, the intensity of the ultrasound field within the treatment area and from there to infer the amount of heat applied to each point within this area.
[0043] Advantageously, the parameterization system may comprise an imaging device 110 , a user interface 130 and a graphical interface 120 .
[0044] The practitioner can view the area to be treated on the display of the imaging device and plan the treatment in the form of a series of shots, each shot being defined by the placement of the probe relative to the area to be treated (its position and orientation relative to it), the focus, i.e. the delay laws for the pulses applied to the various elements of the probe, the pulse energy (power and duration, if applicable) and also the ultrasound frequency.
[0045] Alternatively, the sequence of shots may be predefined by the practitioner using the HIFU device and the corresponding data transmitted to the parameterization system, especially when previous treatments of the patient are recorded in the HIFU device.
[0046] In either case, the treatment area and the successive shots are viewable on the display of an imaging device, which may be, for example, a conventional ultrasound diagnostic device.
[0047] Using the user interface, the practitioner can define additional shots or delete programmed shots, modify the position and / or orientation of the probe, adjust the power and / or duration or repetition rate of a shot, etc. The series of shots can be displayed overlaid on an image of the treatment area.
[0048] Once the nominal treatment parameters are defined (probe position and orientation, shot power and duration, ultrasound frequency, shot repetition frequency, etc.), the simulation module calculates the spatial distribution of the ultrasound field for each shot in near real time and uses this to infer the distribution of thermal dose in the tissue, as described below. This ability to simulate the effect of a sequence of shots in near real time is essential as treatments can now be performed on an outpatient basis.
[0049] The amount of heat can then be mapped on a display screen, and which areas are necrotic and which areas are preserved can be inferred by comparison with a threshold value. Thus, the practitioner can check whether the HIFU Treatment Plan matches the desired target, and if so, verify the transfer of the treatment parameters to the HIFU Device.
[0050] The module 140 can itself compare the results of the simulation with the desired target and iteratively modify the parameters of the HIFU Treatment Device to conform to the treatment plan. For example, the simulation module can adjust the position and / or orientation of the probe relative to the treated area, the power and / or duration of the shot, the speed of the shot, etc.
[0051] In either case, the suitability of the parameterization of the treatment device is verified by the practitioner using the user interface before the parameters are transferred to the HIFU Device.
[0052] FIG. 2 shows diagrammatically a simulation module used in the parameterization system shown in FIG.
[0053] The simulation module uses a meta-model to predict the intensity of the ultrasound field within the treated area using the database 210. More specifically, the composition of the treated area is modeled by decomposing it into different tissue regions, each of which is characterized by geometric and physiological parameters.
[0054] The composition of the treatment site may vary from patient to patient, depending on the geometric and physical parameters of the tissue areas that make it up, such as fat, blood, skin or soft tissue of an organ.
[0055] The geometric parameters of the different tissue regions may be, for example, thickness, radius of curvature, and any other parameter that describes the shape or volume of such regions.
[0056] Physiological parameters of the tissue region may include, among others, the acoustic attenuation coefficient, acoustic impedance, density, specific heat, thermal conductivity, and temperature of the tissue.
[0057] The database includes a map indicative of the intensity of the acoustic field within the treated area corresponding to a plurality of possible configurations of the area and a plurality of treatment parameters, and more specifically, for each of said plurality of configurations, the database includes a map indicative of the pressure field within the treated area.
[0058] For example, the database may contain maps indicating pressure fields corresponding to different thicknesses of skin and fat layers, sizes or values of geometric and / or physiological parameters of organs, etc. The maps may be stored in the database corresponding to different treatment parameters, in particular different relative positions and orientations of the probe and the treated area.
[0059] Each map is associated with an N-tuple sample of these N geometrical and physical parameters. For example, the database contains pre-calculated distributions of the acoustic field intensity in the treated area for a given inclination of the probe, a given thickness of the skin, a given thickness of the fat, and a value of acoustic attenuation in the organ. For each of these configurations, the distributions themselves were obtained by offline simulation (e.g., using the CIVA simulation platform). It is important to note that such simulations require significant computing resources and are therefore incompatible with real-time limitations.
[0060] The prediction module 220 extracts from the database one or more ultrasound field maps that correspond closest to the geometric and physical parameters that define the envisioned treatment protocol, which includes, among other things, the sequential positions and orientations of the probe relative to the area to be treated.
[0061] These treatment parameters may be nominal parameters initially provided by the HIFU Device and / or modified by the practitioner using the imaging device 110 and user interface 130 .
[0062] A prediction module interpolates the ultrasound field maps thus obtained to obtain maps corresponding to the geometrical and physical parameters of the treatment.
[0063] This ultrasound field map is acquired for each shot in the probe's local reference coordinate system and then transformed by changing the reference coordinate system to a map in the treatment site's reference coordinate system.
[0064] The map of the treatment area is provided to a module 230 for estimating the amount of heat to be applied, which calculates the temperature rise induced by the delivery of ultrasound energy to each point on a grid of points within the treatment area.
[0065] The module 240 for estimating tissue reaction then determines whether at each point on the grid the applied amount of heat corresponding to the accumulation of thermal heating over time will cause tissue necrosis. To do this, this module can access physiological parameters of various tissues stored in the database 210. For example, for a given tissue, exceeding a threshold amount of applied heat can be one criterion for concluding that the tissue is destroyed. However, if this threshold is not exceeded over the period of time, the tissue can be considered to be spared. If necessary, the criterion is expressed as a probability of destruction based on statistics already obtained for the tissue.
[0066] This allows a map of the necrotic area or probability of tissue necrosis to be overlaid on an image of the treated area on the display of the imaging device 110 .
[0067] Advantageously, the module for adjusting the treatment parameters uses a cost function that depends on the differences observed at each point on the destroyed regions, which is minimized on condition that the destruction criterion is not met in the preserved regions, and if necessary, the different destroyed regions are assigned weighting factors in the cost function according to the importance of their inclusion in the treatment.
[0068] The cost function can be expressed as a sum of identity functions.
[0069] These unitary functions can in particular be associated with each shot, in which case each unitary function can depend in particular on the position and orientation of the probe during the shot, on the power and duration of the pulse, and on the focusing law (which gives the position of the focal spot) applied during this shot.
[0070] The identity function can also be associated with the necrotic tissue area.
[0071] In particular, in some cases, the tissue region to be necrotic can be considered to include multiple sub-regions. In such cases, the cost function can include a sum of unit cost functions, each unit cost function being associated with one of the sub-regions. Of course, one or more shots can be used per tissue region or sub-region to be necrotic.
[0072] Regardless of whether the unit cost function relates to a shot, to a necrotic tissue region or subregion, or to the entire necrotic region, the unit cost function can take into account one or more objectives to be optimized. These objectives include, in particular: the difference between the area or subarea estimated to be necrotic due to one or more shots and the corresponding necrotic area or subarea; The volume of healthy tissue necrotized after one or more shots, The overall (cumulative) duration of one or more shots The number of probe positions to perform a set of shots, specifically all the shots, and It may include a rest period between two successive shots or a sum of such rest periods.
[0073] These objectives are taken into account in the cost function, particularly to improve patient comfort and / or optimize the availability of treatment equipment.
[0074] The constrained cost function can be minimized in a conventional manner using Lagrange multipliers, for example, by associating a Lagrange multiplier with each region to be preserved.
[0075] The cost function can be minimized using gradient descent, or, for a large number of shots, stochastic gradient descent, or a genetic algorithm, for example of the differential evolution type.
[0076] The resulting new treatment parameters are then injected into the prediction module 220 for a new prediction of the ultrasound field.
[0077] At each iteration, the practitioner can view a map of the necrotic and sparing areas to verify the transfer of treatment parameters to the HIFU device.
[0078] FIG. 3 shows diagrammatically the method for predicting the distribution of ultrasonic field intensity used in FIG.
[0079] This prediction method assumes that the treatment area has already been modeled in step 310 into different tissue regions, each tissue region characterized by geometric and / or physiological parameters as described above.
[0080] It is also assumed that the treatment protocol has been modeled shot by shot with treatment parameters such as the position and orientation of the probe relative to the treated area, and the power, duration, delay / phase rule and frequency of the pulses applied to the various transducer elements of the probe, in step 320. The sequence of shots can be described by the trajectory of the probe relative to the treated area, which can be divided into slices if necessary.
[0081] Based on the geometric and physiological parameters of the tissue region and the treatment parameters, the database is searched for relevant configurations of these parameters, e.g., configurations that are closest to or related to values that belong to a range around these parameters, and pre-computed ultrasound field maps associated with these different configurations are then extracted from the database.
[0082] In step 340, the ultrasound field intensity distribution in the treatment region in the local reference frame of the probe is estimated by interpolating the field maps extracted from the database, and this estimation is repeated for each shot in the treatment protocol.
[0083] Finally, in step 350, the reference coordinate system is changed for each shot to obtain the distribution of the ultrasound field in the reference coordinate system of the treatment area.
[0084] FIG. 4 shows diagrammatically the method for estimating the amount of heat applied to the treatment site used in FIG.
[0085] The treatment area is spatially sampled by a grid of points.
[0086] In step 410, the acoustic energy delivered at each point on the grid for each shot is estimated for each point on the grid, taking into account the power and duration of the shot, as well as the attenuation along the propagation paths in various tissue regions.
[0087] In step 420, the bioheat transfer equation (BHTE) is solved using an explicit finite difference method. A description of how to solve this equation is given in J. Chato, Fundamentals of Bioheat Transfer, Springer-Verlag Berlin, Heidelberg, 1990.
[0088] The BHTE can be expressed as follows:
[0089]
number
[0090] In the formula, T p is the temperature at point P at time t, and T A is the temperature of the arterial blood, ρ, C, and k are the density, specific heat and thermal conductivity of the tissue, respectively, and Cb and ω b are the specific heat of blood and the blood perfusion rate, respectively, and finally, Q P is the density of ultrasonic energy absorbed at point P.
[0091] The initial conditions are determined by the body temperature and the arterial blood temperature. Boundary conditions such as the temperature of a gel or liquid between the probe and the patient's body can also be set to facilitate acoustic impedance matching.
[0092] By solving the BHTE, the temperature change over time at each point on the grid can be determined.
[0093] Then, in step 430, the amount of heat applied to each point on the grid is estimated. The amount of heat can be conventionally expressed as the equivalent exposure time to a reference temperature, i.e. 43°C. This is described in the paper by P. Lele entitled "Thresholds and mechanisms of ultrasound damage to "organized" animal tissues", published in the Symposium of Biological Effects and Characterization of Ultrasound Sources, DHEW (publisher) FDA 78-8048, Rockville, MD, pp. 224-239, 1977.
[0094] The equivalent exposure time to the reference temperature at point P is defined as:
[0095]
number
[0096] Where, if T P If <43°C, then R = 0.25, otherwise R = 0.5. end are the start and end times of the HIFU treatment, respectively.
[0097] If the equivalent exposure time exceeds a certain threshold, the tissue is considered necrotic, otherwise it is considered to be spared.
[0098] Other criteria for tissue destruction, for example, time of exposure to temperatures above a threshold temperature, can be envisioned by one of skill in the art without departing from the scope of the present invention.
[0099] The system for parameterizing the HIFU treatment device allows the treatment protocol to be simulated in near real time, and allows the nominal parameters to be adjusted, if necessary, to meet the objectives defined by the contours of the necrotic and sparing areas at the treatment site. The practitioner can intervene at any time in the iterative process to add constraints or remove others. Once the treatment parameters are verified, they are transferred to the HIFU device and the treatment is started.
Claims
1. 1. A method of parameterizing a HIFU treatment device (150) with an ultrasound probe for necrosing at least one tissue region of a treated area of a patient, the treatment comprising a plurality of ultrasound shots and characterized by treatment parameters defining, in particular, a position and an orientation of the probe for each shot relative to the treated area, the treated area being modeled by different tissue regions including at least one necrosed tissue region and one spared tissue region, each tissue region being characterized by geometric and physiological parameters, the parameterizing method comprising: estimating (220) the ultrasound field in the treatment site by means of a meta-model using a database containing pre-computed ultrasound field maps for different values of the geometric and physiological parameters of each tissue region of the treatment site, the ultrasound field estimate being obtained by interpolation of the pre-computed maps; estimating (230) the amount of heat applied to each point on a grid within the treatment area from the ultrasound field within the area; estimating (240) tissue response at each point on the grid to determine whether the applied thermal dose will cause necrosis at this point, thereby defining an estimated region of necrosis and an estimated region of sparing; and adjusting (250) the treatment parameters to minimize a cost function dependent on the difference between the estimated necrotic area and the area of necrotic tissue, provided that the area to be spared is within the estimated area to be spared.
2. the cost function comprises a sum of a number of unitary cost functions, each of which is associated with a shot, a region of necrotic tissue, or a sub-region of a region of necrotic tissue; and / or the difference between the area or subarea estimated to be necrotic due to one or more shots and the corresponding necrotic area or subarea; the volume of healthy tissue necrosed after one or more shots; the overall duration of one or more shots; The number of probe positions to perform a set of shots, specifically all of the shots; the rest period between two successive shots or the sum of such rest periods, 2. The method of claim 1, wherein said parameterizing step is a function intended to minimize or maximize at least one objective selected from among:
3. The method for parameterizing a HIFU therapy device according to claim 1 or 2, wherein said treatment parameters further include duration and repetition rate of said ultrasound shots.
4. 4. The method of parameterizing a HIFU treatment device according to any one of claims 1 to 3, wherein said probe comprises multiple transducers and said treatment parameters include phase and / or frequency and / or power law applied to all of the transducer elements.
5. The method for parameterizing a HIFU treatment device according to any one of claims 1 to 4, wherein the physiological parameters of the tissue region include at least one parameter of density, specific heat, tissue thermal conductivity, blood or tissue blood perfusion rate.
6. 6. A method for parameterizing a HIFU treatment device according to any one of claims 1 to 5, wherein the ultrasound field is estimated in a local reference coordinate system of the probe by interpolating the pre-calculated maps, and the distribution of the ultrasound field in the treatment area is inferred by changing the reference coordinate system.
7. The method for parameterizing a HIFU treatment device according to any one of claims 1 to 6, wherein the thermal mass is estimated by solving a heat transfer equation in the different tissue regions taking into account the ultrasonic energy absorbed at each point on the grid during each ultrasonic shot.
8. 8. A method for parameterizing a HIFU treatment device according to any one of claims 1 to 7, wherein the results of the treatment are simulated at each point on the grid by calculating the amount of heat absorbed at that point in the form of an exposure time equivalent to a reference temperature, and the tissue region is considered to be necrotic at that point if the time exceeds a predefined threshold, and is considered to be spared otherwise.
9. The method of parameterizing a HIFU therapy device according to claim 8, wherein said cost function depends on the difference between the extent of the necrotic tissue area and the extent of the estimated necrotic tissue area.
10. The method for parameterizing a HIFU treatment device according to any one of claims 1 to 9, wherein during the step of adjusting (250) the treatment parameters, the treatment parameters are iteratively adjusted using gradient descent, stochastic gradient descent, or a genetic algorithm.
11. 11. A method for parameterizing a HIFU treatment device as described in any one of claims 1 to 10, wherein for at least one treatment parameter adjustment iteration, the estimated necrotic tissue area and / or the estimated spared tissue area are displayed on a display such that the necrotic tissue area and / or the spared tissue area are overlaid on an image of the treatment site.
12. 1. A system for parameterizing a HIFU treatment device with an ultrasound probe for necrosing at least one tissue region of a treatment site of a patient, the treatment comprising a plurality of ultrasound shots and characterized by treatment parameters defining, in particular, a position and orientation of the probe for each shot relative to the treatment site, the treatment site being modeled by different tissue regions including at least one necrosed tissue region and one spared tissue region, each tissue region being characterized by geometric and physiological parameters, the parameterizing system comprising: a module (220) for estimating an ultrasound field in the treated area by means of a meta-model using a database (210) in which pre-computed ultrasound field maps for different values of the geometric and physiological parameters of each tissue region of the treated area are stored, the module (220) estimating the ultrasound field by interpolation of the pre-computed maps extracted from the database; a module (230) for estimating, from the ultrasound field in the region, the amount of heat to be applied to each point on the grid in the treatment region; a module (240) for estimating tissue response at each point on said grid to determine whether the applied thermal dose will cause necrosis at that point, thereby defining an estimated region of necrosis and an estimated region of sparing; and a module (250) for adjusting treatment parameters, provided that the area to be preserved is within the estimated area to be preserved, to minimize a cost function dependent on the difference between the estimated necrotic area and the area of necrotic tissue.
13. The system of claim 12 , wherein the treatment parameters further include a duration and a repetition rate of the ultrasound shots.
14. 14. The system of claim 12 or 13, wherein the probe comprises multiple transducers and the treatment parameters comprise phase and / or frequency and / or power law to be applied to all of the transducer elements.
Citation Information
Patent Citations
Puncture ablation planning support device and program thereof, and puncture ablation condition determining method
JP2009233043A
Simulation-based focused ultrasound treatment planning
JP2016509506A
Patient Specific Planning and Simulation of Ablative Procedures
US20140296842A1
Systems and methods for treating tumors using targeted neurostimulation
WO2020236956A1
Simulation-based focused-ultrasound treatment planning
US20210000541A1
Cited By
Simulation evaluation method based on focused ultrasound and electronic equipment
CN120502045A
Superficial biological tissue heat effect simulation method and application thereof
CN121706324A
